Further, it has been shown that probiotics exert an anti-inflammatory effect by reducing the expression of miR-155 in mice with colitis and can also decrease the expression of miR155 in colorectal cancer, along with its target gene Kirsten rat sarcoma virus (KRAS) [24,25]. The gene discussed is KRAS; the disease is colorectal cancer.